Acute Sinusitis News Today

Meta-analysis shows fewer treatment failures, but which children benefit is mostly unclear

1. There is no significant difference in treatment failure between pediatric patients taking amoxicillin versus amoxicillin-clavulanate for acute sinusitis. 2. Adverse events were more common in patients who took amoxicillin-clavulanate as compared to amoxicillin. Evidence Rating Level: 2 (Good) Study Rundown: Acute sinusitis is a prevalent condition in children, and antibiotics are frequently prescribed for

The services will allow Britam Medical Insurance clients to access medical services at these pharmacies, for minor and uncomplicated ailments

This new data on younger acute sinusitis patients may indicate the value of testing for specific bacteria at the time of presentation in order to lower the use of antibiotics for this condition.

Bacterial testing of children with acute sinusitis may cut unnecessary antibiotic use, researchers report.

According to Future Market Insights (FMI), an ESOMAR-certified consultancy, the global Sinus Therapeutic Drugs Market size will reach US$ 6.35 billion by 2032, rising at a stable CAGR of 4% through 2032.One of the most important aspects driving the Sinus Therapeutic Drugs market is the introduction of biologics.Omal...

Empiric rhinosinusitis treatment is rife with antibiotic overuse. Are there ways to improve antibiotic stewardship for this common diagnosis?

This discord has implications for diagnosis and management.

The global sinus therapeutic drugs market will reach US$ 4.29 Bn by 2030, growing at a steady CAGR during 2020-2030, according to a research conducted by ESOMAR-certified firm, Future Market Insights (FMI)The development of biologics is amongst the most important factors catalysing the sinus therapeutic drugs market...

The global sinus therapeutic drugs market will reach US$ 4.29 Bn by 2030, growing at a steady CAGR during 2020-2030, according to a research conducted by ESOMAR-certified firm, Future Market Insights (FMI)The development of biologics is amongst the most important factors catalysing the sinus therapeutic drugs market...